Analyst Ratings for Adeptus Biotechnologies Corp. (ADPT)
ADPT Rating Summary
ADPT Price Target Summary
- Highest: $35.00 (Goldman Sachs)
- Lowest: $20.00 (Craig-Hallum)
- Average: $29.31
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$29.31 (+22%)
* Over Last 12-Mos
Rating Score: 7.6 / 10
Percentile Rank: 80%
Avg. $ Target:
$29.31 (+22%)
* Over Last 12-Mos
Rating Score: 7.6 / 10
Percentile Rank: 80%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/29/2026 | Goldman Sachs | Evie Koslosky | New Coverage | Buy (N/A) |
35.00 (N/A) |
28.51 (24.02) |
-15.75% | Details |
| 12/2/2025 | Morgan Stanley » Updated 10/13/2026 |
Kallum Titchmarsh | New Coverage | Equalweight (N/A) |
27.00 (22.00) |
19.66 (24.02) |
22.18% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
